Idexx has launched Pet Resist (www.petresist.com), an online map of the levels of antibiotic resistance recorded in cats and dogs by the company over the past five years.
The map displays geographical variations in resistance to the top 10 antibiotics used in cats and dogs.
Simon Wootton, UK CAG Marketing Manager from Idexx said: "The ability to select the most appropriate antibiotic prior to testing may increase the effectiveness of treatments and reduce the number of return visits. We believe that this new service will also help prolong the effective life of existing antibiotics at a time when there is considerable pressure on the profession to reduce their use."
Pet Resist shows levels of resistance overlaid on an interactive UK map down to individual postcode areas. You enter the postcode, the antibiotic (amoxicillin, ampicillin, cefaliexn, etc) and the suspected organism (E coli, S aureus, etc), after which you'll be able to see the level of resistance based on historical data from the past five years, and use this to help choose appropriate therapies.
Simon added: "We have used results of MIC tests on over 200,000 samples submitted to Idexx to develop the database upon which the resistance levels are based. The data will be continually updated as we receive more samples at our Wetherby laboratory, further increasing the accuracy and value of the service to vets and their clients."
Novartis Animal Health UK has announced a strategic partnership with Procter & Gamble (P&G) Pet Care, maker of the Eukanuba and Iams brands.
As part of the arrangement, the Novartis sales team will start detailing P&G's pet nutrition products to veterinary practices from April 1, 2014 in the UK and at a later stage in Ireland.
Novartis says the partnership brings together two highly complementary portfolios: Novartis is a leader in pet health areas in which P&G's Eukanuba Veterinary Diets have acknowledged strong clinical formulations, specifically dermatology, nephrology, and orthopaedic conditions. The partnership is designed to offer veterinary surgeons a holistic and flexible portfolio in key canine and feline health areas, as well as increased commercial and technical support and partnership from the Novartis sales team.
Simon Harris, sales & marketing manager at Novartis said: "Novartis Animal Health already offers expertise in key companion animal diseases together with innovative veterinary medicines. Based on research done with veterinary customers, we believe nutrition also plays an important role in disease management in pets, making our strategic cooperation with P&G Pet Care a natural fit that offers real benefits to veterinarians and their patients."
Dr. Penny Watson, Senior Lecturer in Small Animal Medicine at the University of Cambridge, said: "Clinical nutrition plays a key role in patient management and is an important complement to medicine in order to achieve a successful outcome. This combination of Eukanuba Veterinary Diets and Novartis Animal Health products helps highlight the importance of dispensing clinical diets as part of a multi-modal approach to effective patient management. Additionally, high quality nutrition is also recommended by vets as part of a normal day-to-day healthy lifestyle."
The partnership will be launched at the BSAVA Congress. The two companies say they'll have a joint presence at the event to showcase the strength and versatility of the combined Novartis and P&G Pet Care portfolio to the veterinary community.
The recall is due to the fact that particulates have been found in identified batches of product during routine stability testing.
The affected batches are:
This issue only applies to the batches listed above. All other batches and the 20 ml pack size are not affected.
For further information regarding the recall, contact Richard Beckwith on 07584 099536 or: richard.beckwith@jurox.co.uk.
The vaccine has been developed from Suvaxyn Circo+MH RTU, and also contains MetaStim as adjuvant 1.
MetaStim is an emulsion containing a metabolisable (non-mineral) oil and is used in vaccines to help elicit both humoral and a cell-mediated immune responses. Zoetis says it is thought to preserve the vaccine components so the antigens are released slowly as compared to other types of adjuvants2.
Alvaro Aldaz, Director Commercial Development and Innovation, Swine, Zoetis, said: "The safety and efficacy of MetaStim has been well documented given its use in several swine, cattle and equine vaccines for the past several years.
"In fact, the MetaStim adjuvant is currently used in our bivalent vaccine – Suvaxyn Circo+MH RTU. Suvaxyn Circo is the monovalent PCV2 fraction of the parent vaccine and it delivers a similar performance profile for PCV2 protection."
More than 250 million pigs are vaccinated against Circovirus every year in Europe.
Professor Hans Nauwynck, Director of the Laboratory of Virology at Ghent University said: "Vaccination of piglets against Circovirus has become a standard in pig farms across Europe.
"The goal is achieving strong immunity, both cell mediated and antibodies, against a virus that is always in the farm.
"Veterinarians should consider several factors when deciding the best timing for vaccination, being especially important the levels of maternal immunity in the pigs to be vaccinated, the presence of co-infections like PRRSV and the expected infection pattern in the farm."
Suvaxyn Circo is a new tool for veterinarians and producers who prefer monovalent vaccines. In situations where early vaccination of piglets against M.hyo is preferred, for example using Suvaxyn MH-One which is licensed for administration from one week of age, there will be a need to give a separate monovalent vaccine to cover PCV2. In such cases, Suvaxyn Circo from three weeks of age can be considered as an option.
Suvaxyn Circo is available in 50- and 125-dose vials.
For more information, contact your Zoetis representative.
References
Agria Pet Insurance has announced the launch of a new campaign to highlight the threat to animals from everyday poisons and toxins.
As part of its campaign, the company is encouraging vets and nurses to help clients keep their pets safe by sharing knowledge about specific toxins - increasing awareness of substances which can cause harm.
To support vets in advising clients, Agria has produced a poster designed for in-practice display (pictured right, click to enlarge), covering some of the main threats to cats and dogs that owners may come across in their everyday lives. Dangers include: ingestion of antifreeze and paracetamol by cats, certain human foods and rock salt by dogs.
International Cat Care, currently running the campaign ‘Keeping Cats Safe’ in conjunction with Agria, feels that many poisonings could be prevented if only owners knew the risks.
Claire Bessant, from the charity, said “Accidental poisonings are heartbreaking because they are so often preventable - owners just weren’t aware of the dangers. Even worse, sometimes people are trying to help their animals - such as when owners give paracetamol, unaware that it can be lethal for cats.
"We’re delighted that Agria is helping reduce the risk of poisoning with this veterinary campaign and we encourage vets to do their bit and display a poster." To order a copy of Agria’s poster – ‘Responsible Pet Ownership Month – taking extra care of your pet!’– to display in your practice, email the Agria vet team at admin.vet@agriapet.co.uk, or call them on 03330 30 83 90.
Prevexxion RN is composed of a serotype-1 construct vaccine which Boehringer says offers a unique balance between safety and efficacy against the most virulent types of Marek’s disease virus strains.
Prevexxion RN+HVT+IBD is a solution combining Prevexxion RN and Vaxxitek HVT+IBD in one ampoule. It is designed to meet the needs of customers in long-life bird segments with protection from the hatchery.
Prevexxion RN vaccines are available in ampoules of 1000, 2000, and 4000 doses, frozen in liquid nitrogen.
Jerôme Baudon, Head of Poultry at Boehringer Ingelheim, said: “Our Prevexxion RN range provides value through innovation to Marek sensitive poultry producers looking for continuous live production productivity improvement and effective protection. Field and lab experiments conducted worldwide demonstrated its safety, efficacy and its strong, early, and long-lasting protection through the lifespan of the birds and against very virulent Marek’s disease challenge.
Prevexxion RN is the new golden standard for Marek's disease vaccination programs2”.
For more information, contact your Boehringer Ingelheim representative.
Reference
Sean became interested in animal welfare science as an undergraduate veterinary student, when he was awarded a Universities Federation for Animal Welfare (UFAW) Vacation Scholarship to investigate the welfare of caged zebra finches housed under typical pet shop conditions.
Six years later, having been instrumental in developing BVA policy in supporting a ban on the importation of wild-caught birds into the European Union to be kept as pets, Sean represented the position in Brussels and an EU-wide ban was introduced in 2007.
As BVA President in 2015/16, Sean initiated and led the production of BVA’s Animal welfare strategy. Developed through consultation with representatives from across the profession and other sector stakeholders, 'Vets speaking up for animal welfare' lays out a number of strategic actions based on the veterinary profession’s unique opportunity and responsibility to advocate animals' best interests at individual, community and political levels.
The strategy aims to further expand BVA’s animal welfare advocacy; provide tools and support to BVA members in areas such as veterinary ethics; and foster collaboration with other animal welfare-focused partners such as the recently launched BVA/British Cattle Veterinary Association (BCVA) position paper promoting analgesic use alongside local anaesthesia for routine surgical procedures on calves. To help build BVA’s international animal welfare agenda, Sean has recently been appointed as a member of the FVE Animal Welfare Working Group.
Another important project during Sean’s BVA Presidency was the jointly led BVA/RCVS Vet Futures project. He assisted in developing the Vet Futures report, which identifies veterinary leadership in animal health and welfare as one of the six key ambitions in its 2030 vision for the veterinary profession. While President he also produced an online video with the international animal welfare organisation World Animal Protection on the importance and relevance of animal sentience to the veterinary profession.
British Veterinary Association President Gudrun Ravetz, said: "Improving animal welfare has always been the focus of Sean’s veterinary career, through veterinary practice and policy and developing the profession’s role in advancing animal welfare. Since his undergraduate research and subsequent postgraduate studies in animal welfare, he has undertaken a wide range of overseas volunteer projects and continues to champion and promote understanding of animal welfare at individual, community, national and international levels on a daily basis.
"Sean also led on BVA’s landmark Animal welfare strategy, championing the role of vets as advocates of animals’ best interests and sending a clear signal that the veterinary profession will be a considerable force for good, for animals and for an increasingly compassionate society in the years ahead.
"Sean has made a difference to the lives of many animals with his dedication to animal welfare. I am delighted that Sean is being recognised on an international stage for his fantastic work in the field of animal welfare with this important award."
On receiving his award, Sean said: "It is excellent that WVA has further underpinned its commitment to animal welfare, in line with global society’s expectation of our profession as animal welfare leaders, through the establishment of the Global Animal Welfare Awards. It’s a great honour to be a recipient, which is tribute to my driven and forward-looking colleagues at BVA and PDSA. I thank them, as well as the many other organisations, institutions and individuals who have given me invaluable opportunities and encouragement during my career to date."
The materials include eye-catching waiting room bunting, wall displays, posters, leaflets and leaflet holders which offer hints and tips on how to look after pets while fireworks are going off.
Ceva is also launching a series of eight three-minute fireworks videos which offer advice to owners about how they can 'Help take the fear out of fireworks' and more information about Adaptil and Feliway. The videos are presented by Emma Carr, training and charity key account manager at Ceva Animal Health and are available to download via Vimeo and Ceva’s social media tool kit.
Veterinary practices are being encouraged to use the new materials to take part in Ceva’s annual fireworks waiting room display competition, which offers a £200 voucher for the overall best display and luxury chocolate hampers for 10 runners up (hint: entrants get additional credit if they build a display den and plug in an Adaptil Calm Home Diffuser nearby).
Practices taking part in the competition can post pictures of their dens and waiting room displays on Ceva Animal Health UK's Facebook page in October.
Abigail King, senior behaviour product manager at Ceva Animal Health, said: "The extensive marketing support we are putting behind Adaptil and Feliway in the run up to the fireworks season will help educate pet owners on the measures that can be put in place to help their pets with firework fears, while highlighting the benefits of our products."
For further information, or to request the new waiting room material, contact your local account manager or email: cevauk@ceva.com.
However, many of the causes of above-inflation increases in the cost of veterinary care go well beyond the remit of the CMA and it therefore has limited scope to propose or enforce changes that will likely have any significant impact on costs.
The CMA concluded that the main barriers to healthy competition are: owners not being given enough information, barriers to owners being able to make appropriate choices and an out-of-date regulatory environment.
To correct these issues, the CMA has proposed that veterinary practices should be compelled to:
Given that treatment inflation, rather than a lack of competition, is likely the biggest contributory factor to rising veterinary costs, it seems unlikely that providing price lists, itemised bills or written estimates will do much more than increase the administrative burden on veterinary practices.
What's more, it is very hard to see how price lists and estimates can ever be truly representative in such a complex area as medicine.
So these proposed measures are no more than rearranging deckchairs on the Titanic.
To switch metaphors, the problem is less that pet owners don't know what they're buying and more that the veterinary profession is trying to sell caviar to people who only want or can afford a Big Mac and large fries.
Real change can only be driven by the veterinary profession - not just veterinary surgeons, but the regulator, universities, manufacturers and others, after reflecting on the real, rather than assumed needs of its clients and patients, together with the ethical issues in play.
A good starting point for that reflection is the new book Veterinary Controversies and Ethical Dilemmas, available now: https://www.routledge.com/Veterinary-Controversies-and-Ethical-Dilemmas-Provocative-Reflections-/Clutton-Murphy-Stephens-Taylor/p/book/9781032579863
https://www.gov.uk/guidance/understanding-the-cmas-provisional-decision-in-its-vets-market-investigation
The figures came from an analysis of over 100,000 calls made to VidiVet by owners when their normal practice was closed, between 2021 and 2024.
So far in 2024 36% of VidiVet’s calls have been gastrointestinal cases, 25% skin cases, 14% musculoskeletal and 3.7% post-surgical issues.
The advice given to many of these cases was that an emergency visit to an out-of-hours (OOH) clinic wasn’t necessary, but to monitor at home then attend their own vet practice for any workup, diagnostic tests, medication etc.
The company is now encouraging practices to consider using it's triage service over Christmas, when practices and emergency clinics often experience an increase in OOH workload.
This, it says, is a win-win situation as it relieves pressure on OOH clinics, brings revenue back to veterinary practices and also saves clients money, stress and time.
Ben Sweeney, Veterinary Surgeon, CEO and Founder of VidiVet said: “When I launched VidiVet, vet practices were understandably concerned that digital vet services could drive work away from their clinics.
"We hope this new data shows the opposite, and how it can directly benefit practices in a way they might never have imagined.
"What VidiVet has actually done, as was our belief from the get-go, is to drive the bond with clients even closer as well as providing a revenue opportunity for the practice whilst prioritising pet health and welfare.
"This is because the added benefit of a service like ours alleviates part of the immense burden on clinical teams from front of house to the surgical teams, without them losing control.
Kate Higgins MRCVS, owner of Village Vets Crosby & Formby, said: “Over the last six months we’ve saved our clients collectively an estimated £75,000 in emergency vet fees by using VidiVet.
"They were able to be reassured out-of-hours whether their pet did or didn’t need emergency treatment.
"Those that did were able to be treated swiftly by an out-of-hours clinic, and those that did need treatment but not urgently, were able to come to us during our usual working hours, not incurring emergency fees.
"What is even better for us (and our clients) is that we have the case notes from their call with VidiVet ready and waiting for us when we’re open, so we’re up to speed with what the issue has been and what advice has already been given – which is a crucial time saver for both parties.”
www.vidivet.com
Photo: Emma Paine
Sheldon is managing director of RVC Veterinary Practices Ltd and principal at Acorn House Veterinary Hospital in Bedford. He has been with the practice for 14 years. A graduate of Cambridge University he has a particular interest and a GP Certificate in ophthalmology. He has been a member of the BSAVA Board for the past five years and a volunteer since graduation.
Sheldon says that during his Presidency he will focus on shaping Congress 2022 into the ultimate veterinary get-together as the country begins its release from the challenges and constraints of the pandemic. He said: "With more than 3,300 registrations, the turnout for and particularly the engagement with BSAVA Virtual Congress 2021 was phenomenal, given the challenges the profession is currently facing as a result of the pandemic.
“We intend to build on this for BSAVA Congress 2022, by deploying a cleverly blended format to retain the high degree of accessibility and flexibility that delegates have so enjoyed this year. We will be releasing further details on BSAVA Congress 2022 in the early summer.”
Sheldon says he will also be focusing on BSAVA’s support for the small animal veterinary community as it emerges from the pandemic.
"The profession has shown incredible resilience and dynamism in responding to the changing demands of our patients but we need to be careful that this is not at the expense of our own wellbeing. BSAVA’s community support, practical education and science resources and leadership are all there to support the profession as it pivots to a new way of working.”
BSAVA Virtual Congress 2021 content is accessible for another 6 weeks. Visit https://www.bsavaevents.com/bsavacongress2021/en/page/home.
The manufacturer has identified that there is a potential for decreased levels of the preservative Chlorobutanol hemihydrate in the following batch: J2101-03 Expiry 11/2018.
Oxytobel is distributed in the UK by Bimeda UK. Veterinary practices that have purchased this batch number should contact Bimeda to arrange collection.
Any queries in relation to return of the product or credit for the product returned should be addressed to Kay Cowton, Bimeda UK Sales on 01248 725400 or email: uksales@bimeda.com
For further information on the recall please contact Bela-pharm GmbH & Co.KG: +49 (0) 44 41 873 294.
Entries to the international awards came from 52 countries around the world. Each was assessed by three judges from a panel of industry leaders who are told the website's mission statement and target audience. They then visit the site, assume the role of a target user and judge according to seven criteria: design, innovation, content, technology, interactivity, copywriting and ease-of-use.
VetSurgeon.org scored the highest marks for content, interactivity and copywriting.
VetSurgeon.org Editor Arlo Guthrie said: "VetSurgeon.org was entered by our team of developers at 4Roads Ltd without me knowing about it, so this came as a very nice surprise. Particularly when you consider that other winners of a Standard of Excellence Award included the BBC, Leica, Mitsubishi Electric, Cisco, Dell, Deloitte and Philip Morris. That's very illustrious company to be in!"
Virbac Animal Health has launched 'Spray to Win' competition in which vets who use the topical corticosteroid Cortavance between now and the end of June have the chance to win one of five Canon Ixus Cameras worth £150.
To enter the competition, ask your territory manager for a Spray to Win card, spray the pictured dog to ease his pruritus, and answer one question.
Winning cards will reveal either a camera or a 124 page manual on topical glucocorticoid therapy compiled by a group of the world's leading dermatologists.
Virbac product manager Chris Geddes MRCVS said the purpose of the campaign is to illustrate the efficacy of Cortavance as the first line treatment for all pruritic and inflammatory skin disorders: "As a potent skin-specific steroid with no detectable harmful effects¹ and competitive pricing, it's an ideal first line treatment for all atopic dermatitis cases."
There are also automatic rewards in the form of a clinical handbook on canine dermatology or a didactic atlas on canine dermatoses with every 10 bottles of Cortavance purchased, or get both with 15 bottles.
The supply of spray cards is limited, so anyone wishing to obtain a card is advised to contact their Virbac territory manager as soon as possible, or call 01359 243243.
The RCVS has announced that it has accepted the resignation of council member Bob Partridge.
Bob, who had been an elected member of the RCVS Council since July 2006, tendered his resignation for personal reasons.
Peter Robinson will take up the vacated Council position, as he came next in the ballot in the 2013 election.
Eurovet Animal Health has launched Cardisure, a new look pimobendan which the company claims will help deliver more precise dosing in the treatment of cardiac disease.
Dogs have the widest range in bodyweight of any species, and it's long been a problem accommodating the wide variation in dosage requirements that this leads to. Having to give too many tablets in a day or the need to split small tablets can be very discouraging to owners and may lead to poorer rates of compliance.
Cardisure is available in 1.25 mg, 2.5 mg, 5 mg tablets and a 10 mg tablet size. Eurovet says the tablets are easily divisible and palatable, making it easier all round for pet owners to administer the right dose of medication to their pet.
Eurovet says the benefits of treating heart disease with pimobendan are well-established and that Cardisure gives clinicians a few more client-friendly options when it comes to treating heart disease, as well as being available in smart and professional blister packs for easy dispensing.
VetFinders will recruit for permanent and locum positions for veterinary practices throughout the UK, from administration roles through to nursing staff and vets.
The agency has been founded by a man called Chris Worthington who previously built an engineering recruitment firm called Qualtech Resourcing.
Alongside Chris in the VetFinders team are recruiters Gabrielle Dawson and Martin Wilson, both with over 15 years’ experience in recruitment, Chris’s wife Anna, who is charge of accounting and payroll, and administrator Suzy Buttress.
Chris said: "VetFinders is a business with a purpose, a business with a force for good and a business with a double bottom line! Our approach is totally unique in the industry and it’s what sets us apart. Candidates are already hearing about our message and registering with VetFinders rather than other agencies.
"We have chosen four specific charities and our support for them does not stop at the point of donation. We will also be working closely with them, funding specific projects and working on their front line."
The chosen charities are:
Hope Pastures, in Leeds, which rescues, rehabilitates and re-homes horses, ponies and donkeys.
Moorview Rescue in Harrogate, which has re-homed almost 2000 dogs in the UK since it was set up as a registered charity in 2009.
Nuzzlets, a small charity based near Great Ouseburn in York which specialises in giving loving homes to unwanted animals and enabling young people free access to them for therapy and education.
Blue Cross.
When a candidate is placed by VetFinders, the client can choose which of the four charities they want a percentage of their fee to be donated to. The client and placed candidate will then be given regular updates of how their money has benefitted children and animals, including through photos, videos, emails and website updates.
For more information, visit: https://www.vetfinders.co.uk/
Photo: Top (L-R): Martin Wilson - Veterinary Recruitment Consultant, Chris Worthington - Managing Director. Bottom (L-R): Gabrielle Dawson - Veterinary Recruitment Consultant, Anna Worthington - Finance and Payroll Manager and Suzy Buttress - Administrator.
Of the remaining 47% of the 386 veterinary surgeons, nurses, rehabilitation professionals, practice managers, assistants and students who took part in the online survey, 29% expressed uncertainty about whether the profession is respected, and 18% said they do not feel part of a respected community.
Of those who do not feel part of a respected community, social media bashing and the accusation that you're only in it for the money emerged as repeated explanations.
However, remarks from those who said they DO feel respected included:
"People are always impressed when you say you work in veterinary."
"As a professional clients have a certain respect towards me and I feel like a valued member of the community. People always want to talk to the vet in social situations because we have such a fascinating profession."
"People recognise the hard work to reach the role as a vet and appreciate helping their four-legged family members greatly."
"Having built up longstanding relationships with clients over the years, I feel we have a great sense of belonging. We support local events and get lots of positive feedback on social media etc."
When asked whether their vocation in veterinary medicine was all that they thought it would be, 51% of respondents said yes. Of the others, the three most common reasons why their career had not met expectations were: "Low work-life balance", "Financial concerns" and "High demands from clients".
The three things respondents most aspired to were: "Healthy work-life balance" (81%), Making a difference to the lives of animals" (81%), and "Continue to develop my skills" (78%).
When asked what three things respondents would like to change about the profession, 48% said "Client expectations", 46% said "Recognition as a valued role in society" and 46% said "Financial package".
Founder of VET Festival, Professor Noel Fitzpatrick said: "Despite being part of a profession that feels the stresses and strains of failure, financial pressure, difficult relationships, self-confidence, and even fear on a day-to-day basis, it is heartening to see that collectively we still absolutely find a deep sense of fulfilment and pride in what we do.
"Despite the many challenges we face in our vocation, if there is one thing we can learn from these findings, it is that we are all in it together. We cannot be the best version of ourselves without recognising a common sense of purpose and a desire to support each other, in whatever guise as veterinary professionals.
"We give so much of ourselves in companion animal practice to looking after our patients and the families who love them, we sometimes need to remind ourselves of the need to look after ourselves too and most importantly to look after each other as colleagues and friends sharing the same journey, passion, challenges and responsibilities.
This message is integral to the ethos and interactive learning streams of VET Festival 2018."
The Davies Therapy and Fitness Centre has been developed following two years of planning with the intention of supporting referring practices.
Run by a team of Chartered Veterinary Physiotherapists, hydrotherapists and anaesthetists, it has a large hydrotherapy suite, a therapeutic exercise area and gym, an outdoor exercise area, four spacious consultation and treatment rooms and a bright and airy reception.
Services include physiotherapy, rehabilitation, underwater treadmill therapy, soft supports, splinting and orthotics, fitness and conditioning and acupuncture and pain management clinics.
Good rehabilitation is pivotal to the recovery process following injury or surgery and for the management of long-term conditions such as arthritis. DVS says owners are more likely to be compliant with veterinary rehabilitation and fitness programmes if they can fully understand the importance of the process by working with a friendly, professional team, preferably at a bespoke centre.
Diane Messum, Head of Physiotherapy said: "Our mission is to work with referring practitioners to treat every pet, and their owner, with the utmost care and compassion throughout the entire veterinary process. We aim to minimise pain and restore the animals we treat to their maximum physical and mental wellbeing, with the provision of expert therapy, fitness and pain management."
To find out more visit www.vetspecialiststherapy.co.uk
In next year's election, there are three places on Council for elected veterinary surgeons, with successful candidates serving four-year terms.
The nomination period runs until 5pm on Friday 31 January 2020. In order to stand, candidates need to complete a nomination form, submit a short biography and personal statement and supply a high resolution digital photo.
Each candidate also needs to have two nominators who need to be veterinary surgeons who are on the RCVS Register but are not current RCVS Council members.
Eleanor Ferguson, RCVS Registrar and Returning Officer said: "As always, we would encourage those who are interested in having their say in some of the key debates in the regulatory sphere, such as our under care review, our policies around the impact of Brexit and our vision for new veterinary legislation, to become a candidate.
"RCVS Council is at its best when it encompasses a broad range of perspectives, experiences and knowledge, and so we encourage people from all areas of veterinary life and all levels of experience to put themselves forward and share their expertise and insight."
Nomination forms, guidance notes and frequently asked questions for prospective RCVS Council candidates can be found at www.rcvs.org.uk/rcvscouncil20.
Prospective candidates for RCVS Council are welcome to contact the Registrar, Eleanor Ferguson (e.ferguson@rcvs.org.uk) and the RCVS CEO, Lizzie Lockett (l.lockett@rcvs.org.uk) for more information about the role of the College and/or RCVS Council.
RCVS Council will also be holding its next public meeting on Thursday 23 January 2020, prior to the closure date for Council candidate nominations. Prospective candidates are welcome to attend the Council meeting as an observer. Contact Dawn Wiggins, RCVS Council Secretary, on d.wiggins@rcvs.org.uk if you wish to attend.
Novartis Animal Health has launched Onsior®, a coxib NSAID (non-steroidal anti-inflammatory drug) for the relief of pain and inflammation in both cats and dogs.
According to the company, NSAIDs traditionally inhibit both COX-2 and COX-1 enzymes which can result in common side effects involving the gastrointestinal tract and the kidneys. Onsior, however, targets the pain-causing COX-2 enzymes while sparing the protective actions of COX-1 and is the only coxib licensed for cats as well as dogs.
Novartis says tissue selectivity is a further benefit of Onsior. The drug travels rapidly through the bloodstream to the site of injury or irritation. It then concentrates at the point of inflammation, while exiting the bloodstream very quickly.
Dosed once daily, Novartis says Onsior has an excellent safety profile and fits different administration routes with pain and inflammatory indications, which are:
Kelly Doucette, DVM, Global Technical Services Manager with Novartis Animal Health said: "With the benefits of being tissue selective, sparing COX-1, and having a short blood half-life - as well as being approved for both cats and dogs - Onsior will stand out as the new pain reliever of choice for vets."
Folkert Kamphuis, COO Novartis Animal Health added: "Onsior covers multiple indications, works for cats and dogs, comes in two formulations - oral and injectable - and is very simple to dose, which allows veterinarians to use it as the cornerstone of pain management in their clinics. With this complete range, Onsior will offer veterinarians a convenient solution addressing all their different needs."
The online seminar, which equates to one hour’s CPD, features six UK experts in equine endocrinology, with the objective of supporting equine and mixed practice vets in using the clinical history to guide their interpretation of the basal ACTH test results and subsequent treatment decisions.
The speakers participating in the Equine Endocrine Pioneers Circle are:
Harry Carslake MA VetMB DipACVIM MRCVS: Senior lecturer in equine medicine at the University of Liverpool
Edd Knowles MA VetMB MVetMed DipECEIM MRCVS: Specialist in Equine internal medicine at Bell Equine Veterinary clinic
Professor Cathy McGowan BVSc DipVetClinStud MACVSc PhD DEIM DipECEIM FHEA MRCVS: Head of Department of Equine Clinical Science and Director of Veterinary Postgraduate Education at the University of Liverpool
Dr Nicola Menzies-Gow MA VetMB PhD DipECEIM Cert EM(Int Med) MRCVS: Reader in equine medicine at the Royal Veterinary College
Victoria South MA VetMB CertAVP(EM) DipECEIM MRCVS: Senior assistant at Liphook Equine Hospital
Nicola Steele BVM&S CertAVP(EM) MRCVS: Fyrnwy Equine Clinic and Director of Veterinary CPD (Equine and Large Animal)
The webinar considers when vets should test for PPID and decision-making on the best test to use, how to interpret grey zone results and also how to interpret problematic follow up tests. The experts have different opinions on some of these areas, allowing vets in practice to see the different ways in which cases can be viewed and managed.
These principles are then reinforced by the use of three clinical case scenarios with the patients all having the same basal ACTH result but a different selection of clinical signs.
Liz Barrett, equine business head at Boehringer Ingelheim said: "Since the launch of our Talk About Laminitis initiative in 2012, more than 50,000 horses have benefited from complimentary basal ACTH tests to aid the diagnosis of PPID, however two common areas of uncertainty in interpreting ACTH results still exist. Firstly, the interpretation of borderline, equivocal or ‘grey-zone’ results and when PPID treatment should or shouldn’t be recommended and secondly, the interpretation of follow-up ACTH test results and when to advise altering the treatment dose.
"The Equine Endocrine Pioneers Circle webinar allows vets to update their knowledge on this broad subject area and illustrates that there is often more than one way to approach the diagnosis, treatment and management of the PPID case."
To view the Equine Endocrine Pioneers Circle webinar on the Boehringer Academy visit https://www.boehringer-academy.co.uk/webinar/bil205
VetSurgeon.org has joined forces with referral practitioner Alex Gough to conduct a survey into the profession's attitude to the use of homeopathy in animals.
Whilst the debate continues to rage over its use in human medicine, this is believed to be the first time that there has been a survey of opinion within the veterinary profession.
Alex Gough said: "This should give us an interesting insight into how practitioners feel about one of the more well-known systems of alternative medicine. That in turn may add something to the broader debate outside the veterinary profession."
Arlo said: "We really need as many veterinary surgeons as possible to take part, in order to get the most accurate picture. There are only 8 questions, and it should take less than a minute."
Click here (veterinary surgeons only), to take part in the survey.
A graduate of Aristotle University of Thessaloniki, Greece Johnny went on to spend three years working as a general practitioner in England before starting a rotating internship at Queen’s Veterinary School Hospital, University of Cambridge.
Following a residency in Neurology and Neurosurgery at the Royal Veterinary College he was awarded the Diploma of the European College of Veterinary Neurology (ECVN) in 2014 and joined Davies in the same year.
Johnny has been Chairperson of the Education Committee of the ECVN College since 2018, has been the main author and co-author of numerous publications and regularly lectures in the UK and abroad.
Johnny said: “I am delighted to have been appointed to lead Davies’ neurology team to continue to build on the excellent reputation that we have established in neurology and neurosurgery over the past decade. Specialist and supportive care for neurological patients is paramount and we take pride in treating our patients as if they were our own pets.”
The company says it has already used part of the funding facility to acquire six practices – four in Wales and two in South London, with the aim to attain many more practices in 2017 across the UK.
Medivet now has 169 veterinary practices across the country, making it the fourth largest veterinary group in the UK.
Will Taylor, Corporate Relationship Manager for HSBC in Thames Valley, said: "It is great to see that Medivet has gone from strength-to-strength over the past few years, with an ambitious business. HSBC has enjoyed a long-standing and highly effective business relationship with Medivet and this latest deal will allow the business to carry out its aspiring acquisition plan and continue to grow at a rapid pace."
Dr Arnold Levy, Chief Executive Officer at Medivet, said: "This latest round of funding will allow us to take up a vast amount of opportunities that have become available to us and accelerate the pace of acquisitions of further practices across the country. Last year we acquired over 50 new sites and this year we plan to attain even more, which is significant progress for our business and testament to our strong financial backing."